Literature DB >> 7397706

Therapy of local toxicities caused by extravasation of cancer chemotherapeutic drugs.

R J Ignoffo, M A Friedman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7397706     DOI： 10.1016/s0305-7372(80)80023-5

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  20 in total

1.  Practical cancer chemotherapy: venous access and extravasation.

Authors:  M L Brigden; L N Hughes; J B Barnett
Journal:  Can Fam Physician       Date:  1985-06       Impact factor: 3.275

Review 2.  [Antineoplastic drug-induced extravasation].

Authors:  Maike de Wit
Journal:  Med Klin (Munich)       Date:  2010-11

3.  Prevention of tissue necrosis due to accidental extravasation of cytostatic drugs by a conservative approach.

Authors:  N B Tsavaris; P Komitsopoulou; P Karagiaouris; P Loukatou; I Tzannou; N Mylonakis; P Kosmidis
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 4.  [Prevention, early diagnosis and treatment of chemoextravasation. Practical management in the uro-oncological practice].

Authors:  L Rinnab; M Ringhoffer; R Mayer-Steinacker; R E Hautmann; J Simon
Journal:  Urologe A       Date:  2009-11       Impact factor: 0.639

Review 5.  Cancer chemotherapy agent-induced perivenous extravasation injuries.

Authors:  A Banerjee; T M Brotherston; B G Lamberty; R C Campbell
Journal:  Postgrad Med J       Date:  1987-01       Impact factor: 2.401

6.  Topical dimethylsulfoxide may prevent tissue damage from anthracycline extravasation.

Authors:  H J Lawrence; D Walsh; K A Zapotowski; A Denham; S H Goodnight; D R Gandara
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

7.  Dose-dependent skin ulcers in mice treated with DNA binding antitumor antibiotics.

Authors:  M J Soble; R T Dorr; P Plezia; S Breckenridge
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

Review 8.  Prevention and management of extravasation of cytotoxic drugs.

Authors:  G Bertelli
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

9.  Lack of experimental vesicant activity for the anticancer agents cisplatin, melphalan, and mitoxantrone.

Authors:  R T Dorr; D S Alberts; M Soble
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 10.  [Extravasation of cytotoxic agents].

Authors:  Elisabeth Nogler-Semenitz; Ines Mader; Patrizia Fürst-Weger; Robert Terkola; Sabine Wassertheurer; Pietro Giovanoli; Robert M Mader
Journal:  Wien Klin Wochenschr       Date:  2004-05-31       Impact factor: 1.704
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.